Name: UMIN ID:
Unique ID issued by UMIN | UMIN000025524 |
---|---|
Receipt number | R000029363 |
Scientific Title | A multi-institutional study analyzing effect of a novel lozenge containing polaprezinc for patients treated with high dose chemotherapy followed by hematopoietic stem cell transplantation |
Date of disclosure of the study information | 2017/01/04 |
Last modified on | 2020/05/19 17:44:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/01/04 19:07:26 | ||
2 | Update | 2019/07/08 08:45:29 | Recruitment status Date of IRB Last follow-up date |
|
3 | Update | 2020/01/09 11:56:52 | Number of participants that the trial has enrolled |
|
4 | Update | 2020/01/09 12:04:24 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Institute Email3 Organization Organization Address Address Tel |
|
5 | Update | 2020/01/09 12:06:30 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
6 | Update | 2020/05/19 17:44:04 | Recruitment status |